Einstein-developed treatment strategy may lead to HIV cure
October 21, 2021—(BRONX, NY)—Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein
Stay updated with breaking news from Selective Targeting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
October 21, 2021—(BRONX, NY)—Armed with a novel strategy they developed for bolstering the body’s immune response, scientists at Albert Einstein
Press release content from PR Newswire. The AP news staff was not involved in its creation.
The letter's signatories remind the U.S. Olympic & Paralympic Committee and the International Olympic Committee of their charter commitments and international obligations pertaining to the 1948 UN Convention on the Prevention and Punishment for Genocide.
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Cue Biopharma to Present at the 2021 Frontiers in Cancer Immunotherapy Conference Cue Biopharma, Inc.May 6, 2021 GMT CAMBRIDGE, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, announced today it will give a poster presentation at the New York Academy of Sciences 2021 Frontiers in Can...